Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER_GOV × Papillomavirus Infections × Clear all

Phase

Status

Unknown 8 Recruiting 5 Completed 2 Terminated 1

Sponsor Class

INDUSTRY 8 OTHER 6 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma, Kaposi 2 Rectal Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 HIV Infections 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Tract Infections 1 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Stomatitis 1 Solid Tumor 1 Radiation Injuries 1 Prostatic Diseases 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Complications 1 Polycystic Ovary Syndrome 1 Papillomavirus Infections 1 Pain, Postoperative 1 Obesity 1 Neoplasms, Squamous Cell 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 1 Engerix-B 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01082861 2010-03-19

TANGO

National Institute for Public Health and the Environment (RIVM)

Phase 4 Terminated

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡